Russian Pharmaceutical Industry Leader

Products

Rifampicin
Pharmacotherapeutic group
Rifamycin antibiotic
International name
Rifampicin
Dosage form
Coated granules
Description Manufacturer Leave a feedback
Antituberculosis drug. It is a broad spectrum semisynthetic antibiotic. At low concentrations, rifampicin has a bactericidal effect against Mycobacterium tuberculosis, Brucella spp., Chlamydia trachomatis, Legionella pneumophila, Rickettsia typhi, Mycobacterium leprae, and against some Gram-negative microorganisms when used at high concentrations. It is effective against both extra- and intracellular microorganisms and inhibits their DNA-dependent RNA-polymerase. When used as monotherapy, rifampicin resistant bacteria are selected relatively quickly. No cross-resistance with other antibiotics develops.
Send
NAME AND SURNAME*
E-mail
Subject*
Message*
Captcha*
* — Required field